E P Armstrong

Summary

Affiliation: University of Arizona
Country: USA

Publications

  1. ncbi How pharmacists respond to on-line, real-time DUR alerts
    E P Armstrong
    Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson 85721, USA
    J Am Pharm Assoc (Wash) 38:149-54. 1998
  2. ncbi Cost-effectiveness analysis of a new 8% capsaicin patch compared to existing therapies for postherpetic neuralgia
    Edward P Armstrong
    University of Arizona College of Pharmacy, Tucson, AZ 85721, USA
    Curr Med Res Opin 27:939-50. 2011
  3. ncbi Cost-effectiveness of early compared to late inhaled nitric oxide therapy in near-term infants
    Edward P Armstrong
    University of Arizona College of Pharmacy, Tucson, Arizona, USA
    Curr Med Res Opin 26:2795-800. 2010
  4. ncbi Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types
    Edward P Armstrong
    Department of Pharmacy Practice and Science, University of Arizona College of Pharmacy, 1295 N Martin Ave, P O Box 210202, Tucson, AZ 85721, USA
    J Manag Care Pharm 16:217-30. 2010
  5. ncbi A Markov cost-utility analysis of escitalopram and duloxetine for the treatment of major depressive disorder
    Edward P Armstrong
    College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA
    Curr Med Res Opin 24:1115-21. 2008
  6. ncbi Economic benefits and costs associated with target vaccinations
    Edward P Armstrong
    College of Pharmacy Drachman Hall, University of Arizona, Tucson, AZ 85721, USA
    J Manag Care Pharm 13:S12-5. 2007
  7. ncbi Cost-utility comparison of escitalopram and sertraline in the treatment of major depressive disorder
    Edward P Armstrong
    University of Arizona College of Pharmacy, Tucson, AZ 85721, USA
    Curr Med Res Opin 23:251-8. 2007
  8. ncbi Skin cancer knowledge and prevention counseling among Arizona pharmacists
    Edward P Armstrong
    Department of Pharmacy Practice and Science, University of Arizona College of Pharmacy, Tucson, AZ 85721, USA
    J Pharm Pract 23:358-66. 2010
  9. ncbi Cost-effectiveness analysis of simvastatin and lovastatin/extended- release niacin to achieve LDL and HDL goal using NHANES data
    Edward P Armstrong
    Department of Pharmacy Practice, Center for Health Outcomes and PharmacoEconomic Research, College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA
    J Manag Care Pharm 10:251-8. 2004
  10. ncbi Burden of illness of hepatitis C from a managed care organization perspective
    Edward P Armstrong
    College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA
    Curr Med Res Opin 20:671-9. 2004

Detail Information

Publications36

  1. ncbi How pharmacists respond to on-line, real-time DUR alerts
    E P Armstrong
    Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson 85721, USA
    J Am Pharm Assoc (Wash) 38:149-54. 1998
    ....
  2. ncbi Cost-effectiveness analysis of a new 8% capsaicin patch compared to existing therapies for postherpetic neuralgia
    Edward P Armstrong
    University of Arizona College of Pharmacy, Tucson, AZ 85721, USA
    Curr Med Res Opin 27:939-50. 2011
    ....
  3. ncbi Cost-effectiveness of early compared to late inhaled nitric oxide therapy in near-term infants
    Edward P Armstrong
    University of Arizona College of Pharmacy, Tucson, Arizona, USA
    Curr Med Res Opin 26:2795-800. 2010
    ..The purpose of this study was to determine the cost-effectiveness of early versus late inhaled nitric oxide (INO) therapy in neonates with hypoxic respiratory failure initially managed on conventional mechanical ventilation...
  4. ncbi Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types
    Edward P Armstrong
    Department of Pharmacy Practice and Science, University of Arizona College of Pharmacy, 1295 N Martin Ave, P O Box 210202, Tucson, AZ 85721, USA
    J Manag Care Pharm 16:217-30. 2010
    ..Persistent infection with an oncogenic HPV type is a known cause of cervical cancer. Therefore, prevention of cervical cancer via HPV vaccination may have a significant financial impact...
  5. ncbi A Markov cost-utility analysis of escitalopram and duloxetine for the treatment of major depressive disorder
    Edward P Armstrong
    College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA
    Curr Med Res Opin 24:1115-21. 2008
    ..To estimate the costs and quality-adjusted life weeks of duloxetine and escitalopram...
  6. ncbi Economic benefits and costs associated with target vaccinations
    Edward P Armstrong
    College of Pharmacy Drachman Hall, University of Arizona, Tucson, AZ 85721, USA
    J Manag Care Pharm 13:S12-5. 2007
    ..In the pharmacoeconomic study of vaccines, it is common for researchers to conduct their analyses from a societal perspective, including direct medical costs as well as indirect costs...
  7. ncbi Cost-utility comparison of escitalopram and sertraline in the treatment of major depressive disorder
    Edward P Armstrong
    University of Arizona College of Pharmacy, Tucson, AZ 85721, USA
    Curr Med Res Opin 23:251-8. 2007
    ..To construct a cost-utility model comparing escitalopram with sertraline in the treatment of major depressive disorders...
  8. ncbi Skin cancer knowledge and prevention counseling among Arizona pharmacists
    Edward P Armstrong
    Department of Pharmacy Practice and Science, University of Arizona College of Pharmacy, Tucson, AZ 85721, USA
    J Pharm Pract 23:358-66. 2010
    ..035). In conclusion, the length of pharmacy practice in Arizona and having a family member or close friend affected by skin cancer significantly impacted a pharmacists' knowledge of skin cancer...
  9. ncbi Cost-effectiveness analysis of simvastatin and lovastatin/extended- release niacin to achieve LDL and HDL goal using NHANES data
    Edward P Armstrong
    Department of Pharmacy Practice, Center for Health Outcomes and PharmacoEconomic Research, College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA
    J Manag Care Pharm 10:251-8. 2004
    ..The purpose of this study was to compare 2 regimens achieving simultaneous LDL and HDL goals...
  10. ncbi Burden of illness of hepatitis C from a managed care organization perspective
    Edward P Armstrong
    College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA
    Curr Med Res Opin 20:671-9. 2004
    ..determine total healthcare costs of HCV patients with and without a human immunodeficiency virus (HIV) infection as a comorbidity...
  11. ncbi Clinical and economic outcomes of an ambulatory urinary tract infection disease management program
    E P Armstrong
    Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, 1703 E Mabel, Tucson, AZ 85721, USA
    Am J Manag Care 7:269-80. 2001
    ..To evaluate the effectiveness of a urinary tract infection disease management program...
  12. ncbi The impact of nonsteroidal anti-inflammatory drugs on blood pressure, with an emphasis on newer agents
    Edward P Armstrong
    College of Pharmacy, University of Arizona, Tuczon, AZ 85721, USA
    Clin Ther 25:1-18. 2003
    ..Both nonselective and selective nonsteroidal anti-inflammatory drugs (NSAIDs) have been reported to increase blood pressure (BP)...
  13. ncbi Relationship between pharmaceutical services characteristics and exposure rates to drug-drug interactions in Veterans Affairs medical centers
    Maysaa H Mahmood
    PharmaceuticalSciences, College of Pharmacy, University of Arizona, Tucson 5721 0202, USA
    Am J Health Syst Pharm 65:1744-9. 2008
    ..The association between the exposure rates of clinically important drug-drug interactions (DDIs) and the structure of pharmaceutical services within the ambulatory care settings of Veterans Affairs medical centers (VAMCs) is discussed...
  14. ncbi Peginterferon alfa-2a versus peginterferon alfa-2b as initial treatment of hepatitis C virus infection: a cost-utility analysis from the perspective of the Veterans Affairs Health Care System
    Wei Shi Yeh
    Center for Health Outcomes and PharmacoEconomic Research, College of Pharmacy, University of Arizona, Tucson, Arizona 85721, USA
    Pharmacotherapy 27:813-24. 2007
    ....
  15. ncbi Potential drug-drug interactions within Veterans Affairs medical centers
    Maysaa Mahmood
    Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona UA, Tucson, AZ 85721 0202, USA
    Am J Health Syst Pharm 64:1500-5. 2007
    ..This study assessed the prevalence of 25 clinically important drug-drug interactions (DDIs) in the ambulatory care clinics of the Department of Veterans Affairs medical centers (VAMCs)...
  16. ncbi Which antifungal agent for onychomycosis? A pharmacoeconomic analysis
    V N Joish
    Department of Pharmaceutical Sciences, College of Pharmacy, University of Arizona, Tucson 85721, USA
    Pharmacoeconomics 19:983-1002. 2001
    ....
  17. ncbi Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions
    Daniel C Malone
    Center for Health Outcomes and PharmacoEconomic Research, College of Pharmacy, University of Arizona, PO Box 210207, Tucson, AZ 85721 0207, USA
    J Am Pharm Assoc (2003) 44:142-51. 2004
    ..To develop a list of clinically important drug-drug interactions (DDIs) likely to be encountered in community and ambulatory pharmacy settings and detected by a computerized pharmacy system...
  18. ncbi Pharmacist workload and pharmacy characteristics associated with the dispensing of potentially clinically important drug-drug interactions
    Daniel C Malone
    College of Pharmacy, University of Arizona, Tucson 85721, USA
    Med Care 45:456-62. 2007
    ..The purpose of this study was to examine pharmacy characteristics that may be associated with dispensed potential DDIs...
  19. ncbi Reasons provided by prescribers when overriding drug-drug interaction alerts
    Amy J Grizzle
    Center for Health Outcomes and PharmacoEconomic Research, College of Pharmacy, University of Arizona, Tucson, AZ 85721 0202, USA
    Am J Manag Care 13:573-8. 2007
    ..To investigate prescribers' rationales for overriding drug-drug interaction (DDI) alerts and to determine whether these reasons were helpful to pharmacists as a part of prescription order verification...
  20. ncbi Industry's perception of presenting pharmacoeconomic models to managed care organizations
    Bridget M Olson
    University of Arizona College of Pharmacy, 1703 East Mabel St, Room 318, PO Box 210207, Tucson, AZ 85721, USA
    J Manag Care Pharm 9:159-67. 2003
    ..Previous research has shown that pharmacoeconomic (PE) data are considered important but may not be optimally utilized by decision makers. No research has compared the effectiveness of different types of PE models...
  21. ncbi Development of computerized alerts with management strategies for 25 serious drug-drug interactions
    John E Murphy
    College of Pharmacy, The University of Arizona, Tucson, AZ 85721 0202, USA
    Am J Health Syst Pharm 66:38-44. 2009
    ..The development of computerized alerts with management strategies for 25 drug-drug interactions (DDIs) is described...
  22. ncbi Angiotensin-converting enzyme inhibitor therapy in patients with heart failure enrolled in a managed care organization: effect on costs and probability of hospitalization
    Jacob Abarca
    Center for Health Outcomes and PharmacoEconomic Research, College of Pharmacy, University of Arizona, Tucson, Arizona, USA
    Pharmacotherapy 24:351-7. 2004
    ..To evaluate the effect of angiotensin-converting enzyme (ACE) inhibitor therapy on risk of hospitalization and resource utilization in patients with heart failure enrolled in a managed care organization...
  23. ncbi Community pharmacy managers' perception of computerized drug-drug interaction alerts
    Jacob Abarca
    Center for Health Outcomes and PharmacoEconomic Research, College of Pharmacy, University of Arizona, P O Box 210207, Tucson, AZ 85721 0207, USA
    J Am Pharm Assoc (2003) 46:148-53. 2006
    ..To examine community pharmacists' attitudes toward computerized drug-drug interaction (DDI) alerts and identify factors associated with more favorable perceptions of these alerts...
  24. ncbi Pharmacoeconomic evaluation of antimuscarinic agents for the treatment of overactive bladder
    Yu Ko
    Department of Pharmaceutical Sciences, College of Pharmacy, University of Arizona, Tucson, Arizona 85721 0207, USA
    Pharmacotherapy 26:1694-702. 2006
    ..To compare the cost-effectiveness of various antimuscarinic agents for the treatment of overactive bladder (OAB)...
  25. ncbi Evaluation of the performance of drug-drug interaction screening software in community and hospital pharmacies
    Jacob Abarca
    Center for Health Outcomes and PharmacoEconomic Research, University of Arizona College of Pharmacy, P O Box 210202 Tucson, AZ 85721 0202, USA
    J Manag Care Pharm 12:383-9. 2006
    ..Computerized drug-drug interaction (DDI) screening is widely used to identify potentially harmful drug combinations in the inpatient and outpatient setting...
  26. ncbi Concordance of severity ratings provided in four drug interaction compendia
    Jacob Abarca
    Center for Health Outcomes and PharmacoEconomic Research, College of Pharmacy, University of Arizona, Tucson 85721-0207, USA
    J Am Pharm Assoc (2003) 44:136-41. 2004
    ..A concerted effort to identify DDIs of the highest clinical importance is needed to design effective strategies to avoid and manage them...
  27. ncbi Workload and availability of technology in metropolitan community pharmacies
    Grant H Skrepnek
    Center for Health Outcomes and PharmarcoEconomic Research, College of Pharmacy, University of Arizona, 1703 East Mabel Street, Tucson, AZ 85721, USA
    J Am Pharm Assoc (2003) 46:154-60. 2006
    ..To assess workload characteristics and the presence of prescription processing technologies within metropolitan community pharmacies in the United States...
  28. ncbi Longitudinal analysis of the use of etanercept versus infliximab determined from medical chart audit
    Jacob Abarca
    University of Arizona College of Pharmacy, Center for Health Outcomes and PharmacoEconomic Research, 1703 E Mabel, P O Box 210207, Tucson, AZ 85721 0207, USA
    J Manag Care Pharm 10:538-42. 2004
    ..To describe the dosing of etanercept and infliximab for the treatment of rheumatoid arthritis (RA)...
  29. ncbi Incremental effects of concurrent pharmacotherapeutic regimens for heart failure on hospitalizations and costs
    Grant H Skrepnek
    College of Pharmacy, University of Arizona, Tucson, AZ 85721 0207, USA
    Ann Pharmacother 39:1785-91. 2005
    ..Inappropriate medication use in patients with heart failure (HF) presents challenges in providing optimal, evidence-based care...
  30. ncbi Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections
    Brian J Kopp
    Adult Critical Care, Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson, AZ 85721 0207, USA
    Ann Pharmacother 38:1377-82. 2004
    ..aureus (MSSA) bacteremia. The clinical and economic impact of MRSA involving other sites of infection has not been well characterized...
  31. ncbi An economic and outcomes assessment of first-line monotherapy in the treatment of community-acquired pneumonia within managed care
    Grant H Skrepnek
    Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, College of Pharmacy, Tucson, AZ 85721, USA
    Curr Med Res Opin 21:261-70. 2005
    ..Study design: Retrospective managed care database analysis...
  32. ncbi Performance of drug-drug interaction software for personal digital assistants
    Natalie A Perkins
    El Rio Health Center Special Immunology Associates, Tucson, AZ, USA
    Ann Pharmacother 40:850-5. 2006
    ..In addition, ePocrates Rx is updated regularly and is easily accessible on the Internet at no cost...
  33. ncbi Fluticasone is associated with lower asthma-related costs than leukotriene modifiers in a real-world analysis
    Edward P Armstrong
    College of Pharmacy, University of Arizona, Tucson 85721, USA
    Pharmacotherapy 22:1117-23. 2002
    ..0014). CONCLUSION: These results suggest that fluticasone is associated with lower asthma-related costs than leukotriene modifiers...
  34. ncbi Prescribers' knowledge of and sources of information for potential drug-drug interactions: a postal survey of US prescribers
    Yu Ko
    Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore
    Drug Saf 31:525-36. 2008
    ....
  35. ncbi Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial
    Daniel Ventura
    Forest Research Institute, Jersey City, NJ 07311, USA
    Curr Med Res Opin 23:245-50. 2007
    ..This trial was conducted to compare the efficacy and tolerability of a fixed dose of escitalopram 10 mg/day with sertraline optimally dosed within its recommended dose range (50-200 mg/day) for the treatment of major depressive disorder...
  36. ncbi Prescribing and self-administration of morphine in Hispanic and non Hispanic Caucasian patients treated with patient-controlled analgesia
    Robert J Adams
    Pharmacy Service, Carl T Hayden Veterans Affairs Medical Center, Phoenix, AZ, USA
    J Pain Palliat Care Pharmacother 18:29-38. 2004
    ..32 +/- 3.00 mg/hr in White patients; p = 0.2711) were discovered. This study identified no statistically significant difference in either opioid prescribing or self-administration between Hispanic and White post-operative patients...